Getting first exposure by vaccination is the ideal way forward
In the long arc of human encounters with infectious disease, viruses that once devastated populations have often settled into the background hum of ordinary illness — and researchers at Emory University and Pennsylvania State University now suggest COVID-19 may follow the same ancient pattern. Published in the journal Science in January 2021, their study draws on the history of other human coronaviruses to argue that, as immunity accumulates through vaccination or natural exposure, this virus will likely recede into a mild childhood ailment. The path there, and the cost of the journey, depends on how swiftly humanity chooses to act.
- In January 2021, COVID-19 is still killing people at scale — filling hospitals, orphaning children, and emptying nursing homes with devastating efficiency.
- A new study in Science disrupts the despair with a longer view: the same virus may one day be little more than a runny nose that keeps a child home from school for a few days.
- The mechanism is well-established — first exposure to any virus hits hardest because the immune system has no memory of it, but every subsequent encounter is met with a faster, quieter defense.
- The critical tension is timing: the transition to endemic mildness is inevitable in historical terms, but the number of deaths between now and then is not fixed — it is a choice.
- Vaccination is the lever: researchers are explicit that reaching herd immunity through mass infection means millions more deaths, while rapid vaccination compresses that suffering dramatically.
- With 11 million Americans having received a first dose by mid-January 2021, the campaign has begun — but the distance between its current pace and the finish line remains the defining question.
In January 2021, COVID-19 is killing people. It is filling hospitals and hollowing out families. And yet researchers at Emory University and Pennsylvania State University have published a study in the journal Science offering a longer view: someday, after enough of the world has been vaccinated or infected, the virus will likely become a mild childhood illness — the kind that sends a kid home with a runny nose before they bounce back within days.
The prediction is grounded in history. The researchers studied what happened with other human coronaviruses, including the one behind SARS in 2003. The pattern is consistent: a virus circulates, infects most people at some point in their lives, and gradually becomes less severe. The first encounter is the worst, because the immune system has no prior template. But the body learns — and every subsequent exposure is met with a faster, quieter defense. In adulthood, people first exposed as children may fight off the virus entirely without noticing.
Lead author Jennie S. Lavine, a post-doctoral researcher at Emory, was direct about the mechanism and the stakes. The study analyzed coronavirus patterns qualitatively rather than through precise mathematical modeling, which means the researchers cannot yet say when this transition will occur — five years, ten, twenty. The timeline depends entirely on how quickly the world builds immunity.
That immunity can arrive two ways: vaccination or mass infection. The researchers are unambiguous about which path they prefer. Waiting for the virus to spread until enough people have been infected means millions more deaths before the threshold is reached. Vaccination compresses that suffering. 'Getting first exposure to happen by vaccination is really the ideal way to get to this endemic state,' Lavine said, 'and how fast we get there is determined by how fast we get people vaccinated.'
By mid-January 2021, more than 11 million Americans had received a first dose of the Pfizer or Moderna vaccine. The campaign was underway but still early. The historical pattern of other coronaviruses suggests COVID-19 will eventually become routine. The open question is how many people will suffer and die in the years before that day arrives — and whether the world can vaccinate fast enough to shorten that distance.
Right now, in January 2021, COVID-19 kills people. It sends them to hospitals gasping for breath. It orphans children and empties nursing homes. But researchers at Emory University and Pennsylvania State University have published a study suggesting that someday—years from now, after enough of us have been vaccinated or infected—the virus will transform into something almost mundane. It will become a mild childhood illness, the kind that sends a kid home from school with a runny nose and keeps them there for a few days before they bounce back.
The researchers didn't pull this prediction from thin air. They studied what happened with other human coronaviruses, including the one that caused SARS in 2003. The pattern is consistent: a virus circulates through a population, infects most people at some point in their lives, and over time becomes less severe. The first time you encounter it—usually as a child—your immune system has no template for fighting back, so the infection hits hardest. You get sicker. But your body learns. The next time you meet that virus, whether years or decades later, your immune system recognizes it and neutralizes it before it can replicate and cause symptoms. You might not even notice you've been infected.
Jennie S. Lavine, the lead author and a post-doctoral researcher at Emory, explained the mechanism plainly: initial exposure is the worst because immunity doesn't exist yet. After that first encounter, whether through natural infection or vaccination, the body has a defense. In adulthood, people who were exposed as children will likely fight off the virus silently, their immune systems doing the work before symptoms can develop. The virus will still be circulating. People will still catch it. But it won't hospitalize them. It won't kill them. It will just be another cold.
The study, published Tuesday in the journal Science, analyzed coronavirus data qualitatively rather than quantitatively—meaning the researchers looked at patterns and trends rather than running precise mathematical models. This matters because it means they cannot yet say when this transition will happen. Will it be five years? Ten? Twenty? Nobody knows. The timeline depends entirely on one variable: how quickly the world builds immunity.
That immunity can come two ways. The first is vaccination. The second is infection. The researchers make clear which path they prefer. If enough people get vaccinated before they encounter the virus naturally, the population reaches what's called herd immunity—the threshold at which the virus can no longer spread efficiently because most people are protected. This route saves lives. The alternative, waiting for the virus to spread through the population until enough people have been infected to achieve herd immunity, would mean millions more deaths while the world waits for that threshold to arrive.
Lavine framed vaccination as the ideal scenario: "Getting first exposure to happen by vaccination is really the ideal way to get to this endemic state, and how fast we get there is determined by how fast we get people vaccinated." In other words, speed matters. Every person vaccinated is one fewer person who will experience COVID-19 as a severe illness, one fewer person who might die, one step closer to the day when the virus becomes routine.
As of mid-January 2021, more than 11 million Americans had received their first dose of either the Pfizer or Moderna vaccine. Over 30 million doses had been distributed. The vaccination campaign was underway but still in its infancy. The question hanging over the study is not whether COVID-19 will eventually become endemic and mild—the historical pattern of other coronaviruses suggests it will. The question is how many people will suffer and die in the years before that happens, and whether the world can vaccinate fast enough to minimize that toll.
Notable Quotes
Our first exposure is the most severe because we have no prior immunity to it. But after that, subsequent exposures trigger milder responses.— Jennie S. Lavine, lead researcher, Emory University
The Hearth Conversation Another angle on the story
So the study is saying COVID-19 will eventually be harmless?
Not harmless—endemic. There's a difference. It'll still circulate, people will still catch it, but it won't kill them. It'll feel like a cold.
How long until that happens?
That's the thing they can't answer. They looked at patterns from other coronaviruses, not precise timelines. It depends entirely on how fast we vaccinate.
Why does vaccination speed matter so much?
Because the first time you meet a virus, your immune system has no defense. You get sickest then. If we vaccinate people before they encounter it naturally, we skip that severe first infection for millions of people.
And if we don't vaccinate fast enough?
The virus spreads through the population naturally. People get infected, many get very sick, some die. Eventually we reach herd immunity anyway, but the cost is much higher.
Is the study saying we'll definitely get there?
Yes. History shows us that's what happens with coronaviruses. They don't stay lethal forever. But the path we choose—vaccination or waiting—determines how many people pay the price getting there.
So this is really about speed, not inevitability.
Exactly. The endpoint is probably inevitable. The suffering between now and then is not.